Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a ...

Caris Life Sciences plans to report its complete fourth quarter and full year 2025 financial results during its earnings call ...

Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...

A recent study reveals that bacteria residing within colorectal tumors form distinct ecosystems closely linked to disease ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

Sarcomas exhibit low mutational burden, complicating precision oncology; NGS identifies potential biomarkers and tumor-agnostic targets. NGS is not routinely supported in sarcoma care; selective ...